Protocol Ledger

Biopharma Industry · Consolidated Sponsor Hub

ViiV Healthcare: Clinical Trials & FDA Approval Profile

ViiV Healthcare (Global / Institutional) sponsors 30 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 11 active protocols (5 recruiting now), 16 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)10.0%
Median Closed Enrollment vs National (145 pts)146 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for ViiV Healthcare
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)30
Active Pipeline (Recruiting Now)11 (5)
Completed vs Stopped Early16 / 3 (10.0%)
Median Closed Actual Enrollment146 participants
Physical Hospital Site Disclosure0.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Explore interactive annual charts and M&A subsidiary rollups in the ViiV Healthcare Interactive Dossier, benchmark peers in Infectious Disease and Vaccines, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI